|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.56 USD | +1.70% |
|
0.00% | - |
| 08-07 | Latigo Biotherapeutics Shares Rise in Nasdaq Debut | MT |
| 08-07 | Latigo Biotherapeutics Prices $345.6 Million IPO | MT |
| 1 day | +1.70% |
| 1 week | 17.22 |  | 22.47 |
| 1 month | 17.22 | | 22.47 |
| Current year | 17.22 | | 22.47 |
| 1 year | 17.22 | | 22.47 |
| 3 years | 17.22 | | 22.47 |
| 5 years | 17.22 | | 22.47 |
| 10 years | 17.22 | | 22.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nima Farzan
CEO | Chief Executive Officer | 50 | 2024-07-21 |
| Director of Finance/CFO | 39 | 2026-01-31 | |
Cynthia Voong
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Nima Farzan
BRD | Director/Board Member | 50 | 2024-07-21 |
Timothy Walbert
CHM | Chairman | 59 | 2024-09-30 |
Sara Bonstein
BRD | Director/Board Member | 45 | 2026-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/6/26 | Other | Chief Executive Officer | 2,902,419 | 6.5735% | ||
| 8/6/26 | Westlake Biopartners LLC
| Other | Company | 13,199,669 | 29.8952% | |
| 8/6/26 | 5AM Venture Management LLC
| Other | Company | 7,325,962 | 16.5921% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -61.18M -52.97M -49.51M -45.25M -85.27M -5.84B -86.6M -581M -228M -2.92B -230M -225M -9.72B | -109M -94.51M -88.33M -80.73M -152M -10.41B -155M -1.04B -406M -5.21B -410M -401M -17.35B |
| Net Debt | - | - |
Employees
-
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | US$18.56 | +1.70% | 598,446 |
- Stock Market
- Stocks
- LTGO Stock
Select your edition
All financial news and data tailored to specific country editions
